The North American Clinical Trials Network (NACTN) works to bring promising therapies out of the laboratory and into clinical trials, in a manner that provides strong evidence of effectiveness and safety.
By uniting experts across the country, NACTN is gathering valid, meaningful data to speed the delivery of new therapies to the community.
NACTN supports a network of clinical centers as well as clinical coordinating, data management and pharmacology sites, all dedicated to establishing best practices in the care and treatment of spinal cord injury. These sites have medical, nursing and rehabilitation personnel who are skilled in the evaluation and management of spinal cord injury. In addition to translating discoveries from the lab into clinical studies, NACTN maintains a patient registry of information that is important to the design and testing of possible new treatments for SCI.
For more information about NACTN and participating clinical centers, please contact NACTN Principal Investigators, James D. Guest, M.D., Ph.D., Clinical Professor, Department of Neurological Surgery at the University of Miami; and James S. Harrop, M.D., Division Chief, Spine and Peripheral Nerve Surgery at Thomas Jefferson University.
Other NACTN participating clinical centers include: Duke University; Medical College of Wisconsin; the University of Maryland; the University of Toronto; and Walter Reed National Medical Center.
